<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A9D05F17-9DA7-41CB-9EA4-29E3E3A3E1D1"><gtr:id>A9D05F17-9DA7-41CB-9EA4-29E3E3A3E1D1</gtr:id><gtr:name>Health and Safety Laboratory</gtr:name><gtr:address><gtr:line1>Harpur Hill</gtr:line1><gtr:line4>Buxton</gtr:line4><gtr:line5>Derbyshire</gtr:line5><gtr:postCode>SK17 9JN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/106CC866-A7E8-4955-9CB1-3537FEF3948F"><gtr:id>106CC866-A7E8-4955-9CB1-3537FEF3948F</gtr:id><gtr:name>Retroscreen Virology Ltd</gtr:name><gtr:address><gtr:line1>The Medical Building</gtr:line1><gtr:line2>University of London</gtr:line2><gtr:line3>327 Mile End Road</gtr:line3><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>School of Life Sciences</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A9D05F17-9DA7-41CB-9EA4-29E3E3A3E1D1"><gtr:id>A9D05F17-9DA7-41CB-9EA4-29E3E3A3E1D1</gtr:id><gtr:name>Health and Safety Laboratory</gtr:name><gtr:address><gtr:line1>Harpur Hill</gtr:line1><gtr:line4>Buxton</gtr:line4><gtr:line5>Derbyshire</gtr:line5><gtr:postCode>SK17 9JN</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/106CC866-A7E8-4955-9CB1-3537FEF3948F"><gtr:id>106CC866-A7E8-4955-9CB1-3537FEF3948F</gtr:id><gtr:name>Retroscreen Virology Ltd</gtr:name><gtr:address><gtr:line1>The Medical Building</gtr:line1><gtr:line2>University of London</gtr:line2><gtr:line3>327 Mile End Road</gtr:line3><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7C63FDE7-7D69-4C6E-B04B-4B92E5BB54B3"><gtr:id>7C63FDE7-7D69-4C6E-B04B-4B92E5BB54B3</gtr:id><gtr:name>Bioprocessing Technology Institute</gtr:name><gtr:address><gtr:line1>Bioprocessing Technology Institute</gtr:line1><gtr:line2>20 Biolopolis Way</gtr:line2><gtr:line3>#06-01 Centros</gtr:line3><gtr:line4>Singapore 138668</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Singapore</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CDF620B2-B3C0-4A7C-AA92-F2F91C009EA7"><gtr:id>CDF620B2-B3C0-4A7C-AA92-F2F91C009EA7</gtr:id><gtr:firstName>Benjamin</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Killingley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800453"><gtr:id>ECD549D9-B073-489D-96E6-9069225828D7</gtr:id><gtr:title>Investigating the human - human transmission of influenza</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0800453</gtr:grantReference><gtr:abstractText>If an influenza pandemic occurs, between one quarter and one third of the entire population are expected to become ill at some point. Everyone will need to work together to reduce and slow the spread of the virus by taking simple hygiene precautions such as hand washing and household cleaning. At the moment we do not know how effective these hygiene measures will be or whether the public will use them. Also, we don?t know enough about how influenza is spread and whether face masks will be useful to members of the public in certain situations. We will perform a clinical trial using volunteers; some will be asked to do things like wash their hands or wear a mask when someone in the household gets a respiratory infection (like a common cold). We will also assess how easy it is to follow this advice. The results will allow the government to give sensible advice to families, based on real evidence, when a pandemic comes. The research will be carried out by teams based at Nottingham University and University College London.</gtr:abstractText><gtr:technicalSummary>Aims: To assess whether non-pharmaceutical countermeasures applied within households can reduce household secondary attack rates of acute respiratory infections (ARI) in winter.

Objectives: In the event of an influenza pandemic, authoritative advice on infection control will be necessary across a wide range of settings from healthcare to general household. The evidence base for non-pharmaceutical interventions to reduce the transmission of ARIs is weak but in the context of pandemic influenza such interventions could prove to be extremely important. On the background of a study called Flu Watch (a community study of behavioural and biologic determinants of Influenza-like illness), a study will evaluate interventions to reduce the transmission of ARIs within households. 

Design: This will be a cluster-randomised, single blinded, intervention study. The investigator will be blind to the randomisation of household to specific interventions. The study will use epidemiological and clinical trial methodologies, and relevant univariable and multivariable statistical analyses. 

Methods: A pilot study will trial the use of hand hygiene education and techniques (e.g. alcohol gels), surface decontamination protocols, and the use of face masks for both the symptomatic subject and other household members. It will explore the most practical and achievable interventions which families find acceptable and which policy makers are likely to consider practical and allow the development of appropriate and robust data collection methods. 
This will be followed by a clinical trial over the next two winter seasons. A community cohort of households in England will be recruited from the MRC General Practice Research Framework. The 4 main arms will be: control (no intervention) vs intervention aimed at contact transmission (hand and surface cleansing) vs interventions aimed at large droplet transmission (masks and social distancing) vs both interventions combined. 
Detailed data collection methods including use of illness diaries and automated telephone-based real-time illness reporting will allow measurements of compliance and effectiveness. A specific problem in such studies is participant compliance with the interventions. This will be addressed by the use of a pilot study to refine the nature of the interventions used and optimise acceptability.

Opportunities: This project provides the chance to construct pragmatic and effective infection control advice that is evidence based. Studies assessing the impact of multiple interventions have not been done before. It will be used to inform pandemic influenza preparedness planning but could also measure the impact of reduced transmission of ARI on sick leave (work or school) outside of a pandemic.</gtr:technicalSummary><gtr:fund><gtr:end>2011-10-05</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-06</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>201155</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Retroscreen Virology Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ITSDG 001- Proof of concept: Confirming the Transmissibility of Experimentally Induced Influenza Infection Using an Approved GMP Challenge Virus</gtr:description><gtr:id>DFBE729B-B43C-4935-988D-9215D8F5ACF5</gtr:id><gtr:impact>A final report has been submitted to the Department of Health and peer reviewed articles have been published</gtr:impact><gtr:outcomeId>CE62E7244E0-1</gtr:outcomeId><gtr:partnerContribution>They provided expertise, facilities and personel to set up and run the experimental challenge study</gtr:partnerContribution><gtr:piContribution>I prepared the study protocol and all study documents and played an active doctor role in screening volunteers and supervising the challenge experiment in a quarantine unit. We hope to attract further funding to perform more work in this area.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>National Institute of Occupational Health and Safety (NIOSH)</gtr:department><gtr:description>Influenza aerosol sampling</gtr:description><gtr:id>7848FAD3-3BA1-45EB-BFA2-9939B6D7F4F6</gtr:id><gtr:impact>This work has enabled the design of studies / experiments which are on-going, looking into the aerosol transmission of influenza.</gtr:impact><gtr:outcomeId>69FDD5C55D9-1</gtr:outcomeId><gtr:partnerContribution>Scientific expertise, advice and equipmentScientific expertise and performance of laboratory studies</gtr:partnerContribution><gtr:piContribution>Organising and facilitating investigations into methods of aerosol sampling.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Health and Safety Laboratory</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Influenza aerosol sampling</gtr:description><gtr:id>8184079C-067C-48E9-ACAB-E5F4673A2DCA</gtr:id><gtr:impact>This work has enabled the design of studies / experiments which are on-going, looking into the aerosol transmission of influenza.</gtr:impact><gtr:outcomeId>69FDD5C55D9-2</gtr:outcomeId><gtr:partnerContribution>Scientific expertise, advice and equipmentScientific expertise and performance of laboratory studies</gtr:partnerContribution><gtr:piContribution>Organising and facilitating investigations into methods of aerosol sampling.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Department of Health meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>39577852-7FC5-4062-BED9-60F9C46DD3F0</gtr:id><gtr:impact>Helping to inform government policy

N/A</gtr:impact><gtr:outcomeId>eLPe3pj2sqX</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>370000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Pandemic Influenza Research</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>8FDC480C-9B86-460F-8AAD-E28AC2540BD1</gtr:id><gtr:outcomeId>EB4C20D13E10</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7200000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant (FOA IP11-001)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Centers for Disease Control and Prevention (CDC)</gtr:fundingOrg><gtr:id>18106713-C5E6-45DF-A3D1-D2EB827DAD1F</gtr:id><gtr:outcomeId>YFoYLRWQvVR0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>260000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Unique influenza research grant</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>AC914781-EDC9-4347-BDC5-8539452853AC</gtr:id><gtr:outcomeId>06FD52221660</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>presentation at WHO meeting</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>4B6A947C-EAF9-4291-BF6D-9EE0B88CAADD</gtr:id><gtr:outcomeId>AkQ4A3enrGM</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>review presented at advisory board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7390D946-DC71-4E29-BA7C-3CE67189989D</gtr:id><gtr:outcomeId>ab1VS1u8gmc</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>95564891-C826-4D65-9446-45109D435C7F</gtr:id><gtr:title>Potential role of human challenge studies for investigation of influenza transmission.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a45d884f39106a5721d35c8e0c962ff"><gtr:id>8a45d884f39106a5721d35c8e0c962ff</gtr:id><gtr:otherNames>Killingley B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>BYecB61HZxL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCECB077-E80D-435F-9B3D-38078784B2D8</gtr:id><gtr:title>Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a45d884f39106a5721d35c8e0c962ff"><gtr:id>8a45d884f39106a5721d35c8e0c962ff</gtr:id><gtr:otherNames>Killingley B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>nMNLSHBUL4K</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7D88AE5-7796-4DD0-8472-4A0A453CBAF0</gtr:id><gtr:title>Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a45d884f39106a5721d35c8e0c962ff"><gtr:id>8a45d884f39106a5721d35c8e0c962ff</gtr:id><gtr:otherNames>Killingley B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>WLGemshvBch</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800453</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5841ECCD-C9B1-4B8B-993F-ACC8E9585125</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.1  Primary preventions interventions to modify behaviours or promote well-being</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>